Stock Region Watchlist
Today's Hot Picks 🔥 Highlights for Tuesday, June 17, 2025
Today's Hot Picks 🔥 Highlights for Tuesday, June 17, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: Before we jump in, remember that this newsletter is for informational purposes only and NOT financial advice. Always do your due diligence before making investment decisions.
Hi Stock Region fam,
Happy Tuesday! It’s another exciting day in the market, and I couldn’t wait to share what’s catching my eye today. Pour yourself a cup of coffee (or tea, no judgment here), and let’s talk about the buzzworthy stocks and stories shaping the landscape right now.
📈 Sunrun ($RUN)
Sunrun continues to impress me with its grit and innovation despite a rocky environment for solar companies. This quarter, they flaunted a 10.1% revenue boost (hello, $504.3M!). But here’s the part that truly made me do a double take: they’re activating over 130,000 home batteries to shore up power grids during summer heat and hurricane seasons. That’s not just corporate responsibility in action; it’s hardcore survival strategy.
That said, Sunrun’s battle isn’t without hurdles. A Senate proposal on phasing out solar tax credits is throwing serious shade on the whole sector. If you ask me, this sector’s volatility needs watching like a hawk.
Key levels:
Upside potential if it breaks above $6.17.
Watch out for a pullback if it dips below $5.67.
It’s a dicey solar world out there, but there’s something hopeful about how Sunrun’s fighting to stay ahead.
💉 Verve Therapeutics ($VERV)
Now, this one’s all about major moves. Verve’s stock skyrocketed a jaw-dropping 75% after Eli Lilly dropped the mic on a $1.3 billion acquisition offer. Honestly, I wasn’t surprised. This company’s lead drug, VERVE-102, looks insanely promising, targeting cardiovascular disease with an approach that could turn chronic care into history.
The Fast Track designation from the FDA cements my faith in Verve’s innovative pipeline. And hey, Eli Lilly, if you’re writing $1.3 billion checks, you must see something huge, right?
Key levels:
Bullish moves above $11.27.
Caution if it wavers under $10.95.
To me, this acquisition is symbolic of how far biotech can push boundaries, and it makes me genuinely excited for the future of medicine.
📱 T-Mobile ($TMUS)
T-Mobile’s in the spotlight for all the right reasons and some shareholder drama. Look, a quarterly dividend of $0.88 per share alone would normally have analysts puffing their chests in celebration. Mix that with a projected 9.3% earnings growth this year, and you’ve got what feels like a recipe for long-term stability.
But, not so fast. SoftBank’s recent share sales, aimed at fueling its AI obsession (because, of course, AI), stirred up some uncertainty in TMUS stock. Even with a bit of shaking, though, I’ll say this much—I’m still bullish on T-Mobile’s growth potential. Solid network, industry innovation, and now dividends? They’re aiming to keep both customers and investors happy, and I like that.
Key levels:
Breaking upward past $225.00 feels like a good sign.
Dropping below $219.00 might signal trouble.
T-Mobile feels like that friend who stays steady in chaos, and honestly, that’s a vibe the market needs right now.
Before You Go…
That wraps up today’s watchlist! Investing can definitely stir up excitement, frustration, and everything in between, but that’s part of the ride, right? I'm genuinely curious to hear what’s sparking your interest lately. Shoot me a reply or chat with us in the Stock Region community.
Final Disclaimer: Stock Region provides market insights as a resource for our amazing members. However, this is NOT financial advice. Always consult with a professional advisor before making investment moves.